Evidence map›Paper›PMID 35888609›Full record

ArticleMedicina (Kaunas, Lithuania)2022

Circulating Omentin-1, Sustained Inflammation and Hyperphosphatemia at the Interface of Subclinical Atherosclerosis in Chronic Kidney Disease Patients on Chronic Renal Replacement Therapy.

Davide Bolignano, Marta Greco, Valentina Arcidiacono, Pierangela Presta, Alfredo Caglioti, Michele Andreucci, Francesco Dragone, Daniela Patrizia Foti, Giuseppe Coppolino

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Davide BolignanoRenal Unit, "Magna Graecia" University, 88100 Catanzaro, Italy.ORCID 0000-0003-3032-245X
Marta GrecoClinical Pathology Lab, "Magna Graecia" University, 88100 Catanzaro, Italy.ORCID 0000-0003-4192-3891
Valentina ArcidiaconoRenal Unit, "Magna Graecia" University, 88100 Catanzaro, Italy.
Pierangela PrestaRenal Unit, "Magna Graecia" University, 88100 Catanzaro, Italy.
Alfredo CagliotiRenal Unit, "Magna Graecia" University, 88100 Catanzaro, Italy.
Michele AndreucciRenal Unit, "Magna Graecia" University, 88100 Catanzaro, Italy.ORCID 0000-0002-7974-3792
Francesco DragoneClinical Pathology Lab, "Magna Graecia" University, 88100 Catanzaro, Italy.
Daniela Patrizia FotiClinical Pathology Lab, "Magna Graecia" University, 88100 Catanzaro, Italy.ORCID 0000-0002-9536-5736
Giuseppe CoppolinoRenal Unit, "Magna Graecia" University, 88100 Catanzaro, Italy.ORCID 0000-0001-8000-0681
Magna Graecia University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AtherosclerosisHyperphosphatemiaRenal Insufficiency, ChronicAdipokinesCarotid Intima-Media ThicknessHumansInflammationPilot ProjectsRenal DialysisRisk FactorsAdipokinesatherosclerosiscarotid intima–media thicknessend-stage kidney diseaseOmentin-1

Identifiers

PMID35888609
PMCPMC9319800
OpenAlexW4283795426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.